A Study of Takhzyro in Teenagers and Adults With Hereditary Angioedema (HAE) in South Korea
ConditionHereditary Angioedema (HAE)
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12+
SponsorTakeda
About this trial
Takhzyro is an approved treatment for hereditary angioedema (HAE) in South Korea. HAE is a rare condition which causes sudden swelling under the skin and inside the body, like in the belly, throat, or genitals. The main aim of this study is to check how safe Takhzyro is in teenagers and adults with HAE in everyday medical care in South Korea. Another aim is to see how well Takhzyro works in everyday medical care.
The treatment of participants and any check-ups will be determined by the treating doctors according to their normal practice. Participants may visit the study clinic several times during the study.
Eligibility criteria
Qualifiers
Participants aged 12 years or older at time of initiation of Takhzyro.
Participants who are treated or will be treated with Takhzyro according to the approved label of South Korea.
The participant or legally authorized representative agrees to participate.
Disqualifiers
Any of the contraindications included in the Prescribing Information (PI) for TAKHZYRO apply.
Participant is currently enrolled in an interventional trial.
Trial design
Treatments tested in this trial
- No intervention
Treatment groups
35 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov